CARDIOMYOPATHY, DILATED, 1KK
|
disease |
|
Disease or Syndrome
|
1
|
17
|
0.700 |
strong |
1.000 |
3 |
17
|
2008 |
2013 |
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE
|
disease |
|
Disease or Syndrome
|
1
|
|
0.700 |
strong |
1.000 |
1 |
|
2017 |
2017 |
Cardiomyopathies
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
925
|
294
|
0.430 |
None |
1.000 |
3 |
|
2012 |
2019 |
Cap Myopathy
|
disease |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome; Congenital Abnormality
|
9
|
4
|
0.330 |
None |
1.000 |
3 |
|
2017 |
2020 |
Hypertrophic Cardiomyopathy
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
560
|
635
|
0.310 |
limited |
1.000 |
3 |
|
2001 |
2017 |
Familial dilated cardiomyopathy
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
83
|
47
|
0.300 |
None |
1.000 |
2 |
|
2008 |
2013 |
Paroxysmal atrial fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
226
|
8
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Nemaline Myopathy, Childhood Onset
|
disease |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Persistent atrial fibrillation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
156
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Atrial Fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
939
|
584
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
familial atrial fibrillation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
157
|
1
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Other restrictive cardiomyopathy
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
5
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Restrictive cardiomyopathy
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
41
|
30
|
0.220 |
None |
1.000 |
2 |
1
|
2014 |
2020 |
Cardiomyopathy, Dilated
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
512
|
509
|
0.130 |
None |
1.000 |
3 |
1
|
2008 |
2019 |
Myopathy
|
group |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
634
|
166
|
0.110 |
None |
1.000 |
1 |
|
2017 |
2017 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
5 |
5
|
2018 |
2019 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
3 |
2
|
2017 |
2019 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
2 |
2
|
2014 |
2019 |
Creatinine measurement, serum (procedure)
|
phenotype |
|
Laboratory Procedure
|
124
|
243
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Creatine kinase measurement
|
phenotype |
|
Laboratory Procedure
|
29
|
51
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Cholelithiasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
252
|
90
|
0.100 |
None |
1.000 |
1 |
1
|
2007 |
2007 |
Cholecystolithiasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
156
|
62
|
0.100 |
None |
1.000 |
1 |
1
|
2007 |
2007 |
Forced expiratory volume function
|
phenotype |
|
Organ or Tissue Function
|
272
|
1169
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Psoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
1308
|
705
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
peak expiratory flow (procedure)
|
phenotype |
|
Laboratory Procedure
|
74
|
119
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |